Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Nelson, Timothy J  [Clear All Filters]
2014
Wyles SP, Yamada S, Oommen S, Maleszewski JJ, Beraldi R, Martinez-Fernandez A, Terzic A, Nelson TJ. Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev. 2014.
Wyles SP, Brandt EB, Nelson TJ. Stem Cells: The Pursuit of Genomic Stability. Int J Mol Sci. 2014;15(11):20948-20967.
Wyles SP, Faustino RS, Li X, Terzic A, Nelson TJ. Systems-Based Technologies in Profiling the Stem Cell Molecular Framework for Cardioregenerative Medicine. Stem Cell Rev. 2014.
Li X, Martinez-Fernandez A, Hartjes KA, Kocher J-PA, Olson TM, Terzic A, Nelson TJ. Transcriptional Atlas of Cardiogenesis Maps Congenital Heart Disease Interactome. Physiol Genomics. 2014.
2015
Oommen S, Yamada S, Peral SCantero, Campbell KA, Bruinsma ES, Terzic A, Nelson TJ. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Res Ther. 2015;6(1):50.
Campbell KA, Li X, Biendarra SM, Terzic A, Nelson TJ. Nos3(-/-) iPSCs model concordant signatures of in utero cardiac pathogenesis. J Mol Cell Cardiol. 2015.
2016
Perales-Clemente E, Cook AN, Evans JM, Roellinger S, Secreto F, Emmanuele V, Oglesbee D, Mootha VK, Hirano M, Schon EA, et al. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability. EMBO J. 2016.
2019
Biendarra-Tiegs SM, Secreto FJ, Nelson TJ. Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Adv Exp Med Biol. 2019.
Saraf A, Book W, Nelson TJ, Xu C. Hypoplastic left heart syndrome: From bedside to bench and back. J Mol Cell Cardiol. 2019.
Biendarra-Tiegs SM, Li X, Ye D, Brandt EB, Ackerman MJ, Nelson TJ. Single-cell RNA-seq and optical electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes reveal discordance between cardiac subtype-associated gene expression patterns and electrophysiological phenotypes. Stem Cells Dev. 2019.
2020
Vincenti M, O'Leary PW, M Qureshi Y, Seisler DK, Burkhart HM, Cetta F, Nelson TJ. Clinical Impact of Autologous Cell Therapy on Hypoplastic Left Heart Syndrome after Bidirectional Cavopulmonary Anastomosis. Semin Thorac Cardiovasc Surg. 2020.
Miao Y, Tian L, Martin M, Paige SL, Galdos FX, Li J, Klein A, Zhang H, Ma N, Wei Y, et al. Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome. Cell Stem Cell. 2020.
Gunnewiek TMKlein, Van Hugte EJH, Frega M, Guardia GSolé, Foreman K, Panneman D, Mossink B, Linda K, Keller JM, Schubert D, et al. m.3243A > G-Induced Mitochondrial Dysfunction Impairs Human Neuronal Development and Reduces Neuronal Network Activity and Synchronicity. Cell Rep. 2020;31(3):107538.
2023
Clemens DJ, Ye D, Zhou W, Kim CSJohn, Pease DR, Navaratnarajah CK, Barkhymer A, Tester DJ, Nelson TJ, Cattaneo R, et al. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. PLoS One. 2023;18(3):e0282151.